2015
DOI: 10.2217/nnm.15.105
|View full text |Cite
|
Sign up to set email alerts
|

Oxime Ether Lipids Containing Hydroxylated Head Groups are More Superior siRNA Delivery Agents than their Nonhydroxylated Counterparts

Abstract: Aim To evaluate the structure–activity relationship of oxime ether lipids (OELs) containing modifications in the hydrophobic domains (chain length, degree of unsaturation) and hydrophilic head groups (polar domain hydroxyl groups) toward complex formation with siRNA molecules and siRNA delivery efficiency of resulting complexes to a human breast cancer cell line (MDA-MB-231). Materials & methods Ability of lipoplex formation between oxime ether lipids with nucleic acids were examined using biophysical techni… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 19 publications
(12 citation statements)
references
References 47 publications
0
12
0
Order By: Relevance
“…Investigating different potential carriers, such as lipids or cell-penetrating peptides, for in vivo delivery of RNA therapeutics is therefore one area of RNA nanotechnology that would benefit from SAS-based approaches. Experiments with NANPs employing various carriers such as magnetic nanoparticles [81], lipids [82], mesoporous silica-based nanoparticles [79], polysilsesquioxane [83], and bolaamphiphiles or ‘bolas’ [84,85] have already been successfully initiated. The use of SANS can significantly improve our current understanding of the interactions between the NANPs and carriers, which can further improve NANP delivery in vivo.…”
Section: Discussionmentioning
confidence: 99%
“…Investigating different potential carriers, such as lipids or cell-penetrating peptides, for in vivo delivery of RNA therapeutics is therefore one area of RNA nanotechnology that would benefit from SAS-based approaches. Experiments with NANPs employing various carriers such as magnetic nanoparticles [81], lipids [82], mesoporous silica-based nanoparticles [79], polysilsesquioxane [83], and bolaamphiphiles or ‘bolas’ [84,85] have already been successfully initiated. The use of SANS can significantly improve our current understanding of the interactions between the NANPs and carriers, which can further improve NANP delivery in vivo.…”
Section: Discussionmentioning
confidence: 99%
“…groups are better transfecting and silencing agents than the saturated and non-hydroxylated lipids [62]. Further detailed studies will validate the application of OELs in broader prospects for RNAi therapy.…”
Section: Oxime Ether Lipidsmentioning
confidence: 88%
“…Oxime ether lipids (OELs) are a relatively new class of cationic agents explored as efficient transfection tools [ 61 , 62 ]. In contrast to commonly used transfection lipids, OELs contain oxime ether bonds ( Figure 2C ) and can be synthesized by simple and efficient click chemistry [ 63 ].…”
Section: Overview Of Nvcvsmentioning
confidence: 99%
See 1 more Smart Citation
“…NANPs’ ability to successfully combat diseases at their source has already been confirmed by multiple animal studies [25,38,39,40,41,42,43]. Additionally, the design principles being developed in RNA nanotechnology address fundamental problems relevant to the biophysics of RNA co-transcriptional folding [24,44,45,46,47], structure–activity relationships [48], and their physicochemical interactions with other classes of biomolecules (e.g., lipids [41,49,50], proteins [51,52]) or inorganic materials [53,54].…”
Section: Introductionmentioning
confidence: 98%